Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Glioma 2Severe Combined Immunodeficiency 1Neuroblastoma 1Neoplasms 1Mucopolysaccharidosis I 1Hematologic Neoplasms 1

Interventions

Polymerase Chain Reaction 6Gene Expression Profiling 5Amplified Fragment Length Polymorphism Analysis 5Immunohistochemistry 4Flow Cytometry 4Blotting, Western 3Microarray Analysis 2Enzyme-Linked Immunosorbent Assay 2Data Collection 2naxitamab 1lorlatinib 1dinutuximab 1Tumor Burden 1Psychiatric Rehabilitation 1Prospective Studies 1Phlebotomy 1Microscopy 1Mass Spectrometry 1In Situ Hybridization, Fluorescence 1Immunosuppression Therapy 1Immunologic Techniques 1Immunoenzyme Techniques 1Gene Rearrangement 1Follow-Up Studies 1Electrophoresis, Polyacrylamide Gel 1DNA Methylation 1Cytogenetic Analysis 1Comparative Genomic Hybridization 1Chromatography, Liquid 1Cancer Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neuroblastoma × Cancer Vaccines × Clear all
NCT00695279 2024-10-30

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

St. Jude Children's Research Hospital

Completed
41 enrolled
CNSOther hematologic neoplasm

Mucopolysaccharidosis I, Neoplasms, Neuroblastoma, Severe Combined Immunodeficiency, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡